z-logo
open-access-imgOpen Access
Mitochondria: Key Organelle in Parkinson’s Disease
Author(s) -
Rubén GómezSánchez,
José Manuel BravoSan Pedro,
Matthew E. Gegg,
Rosa A. GonzálezPolo,
José M. Fuentes
Publication year - 2016
Publication title -
parkinson s disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.748
H-Index - 46
eISSN - 2090-8083
pISSN - 2042-0080
DOI - 10.1155/2016/6230370
Subject(s) - medicine , parkinson's disease , mitochondrion , organelle , key (lock) , disease , bioinformatics , pathology , microbiology and biotechnology , biology , ecology
Parkinsonu0027s disease (PD) is the second most common neurodegenerative disorder, characterized pathologically by loss of dopaminergic neurons in the substantia nigra pars compacta. The etiology of PD is still unknown, involving genetic and environmental factors; however mitochondrial dysfunction plays a central role in PD pathogenesis. In this regard, several PD-related proteins (PINK1, Parkin, DJ-1, LRRK2, and α-synuclein) are linked to mitochondrial function. Mitochondria are highly dynamic organelles involved in essential cellular functions, including energy production, calcium homeostasis, metabolism of amino acids and lipids, mtDNA replication, and programmed cell death. Moreover, mitochondrial homeostasis is tightly regulated by several pathways, including mitochondrial biogenesis, remodeling (fusion/fission), and clearance of damaged mitochondria by autophagy (mitophagy), among others. Mitochondrial dysfunction and the engagement of calcium channels during autonomous pacemaking have been implicated in the increased susceptibility of dopaminergic neurons to cell death in the substantia nigra.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom